Erratum: Tissue-Free Circulating Tumor DNA Assay and Patient Outcome in a Phase III Trial of FOLFOX-Based Adjuvant Chemotherapy (Alliance N0147)
F
Frank A. Sinicrope
(Department of Oncology, Mayo Clinic, Rochester, MN)
D
Diana Segovia
(Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN)
N
Nalin Sharma
(Gastrointestinal Research Unit, Mayo Clinic, Rochester, MN)
S
Steven R. Alberts
(Mayo Clinic Rochester, Rochester, MN)
A
Aaron Hardin
(Guardant Health, Palo Alto, CA)
T
Thereasa Rich
(Guardant Health, Palo Alto, CA)
Q
Qian Shi
Article Details
Journal
Journal of Clinical Oncology
Volume / Issue
Vol. 44, Issue 14
Published
May 10, 2026
Pages
1379-1379
ISSN
0732-183X
Publisher
Lippincott Williams & Wilkins
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
ISSN: 0732-183X Health Sciences
Authors (7)
F
Frank A. Sinicrope
Department of Oncology, Mayo Clinic, Rochester, MN
D
Diana Segovia
Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN
N
Nalin Sharma
Gastrointestinal Research Unit, Mayo Clinic, Rochester, MN
S
Steven R. Alberts
Mayo Clinic Rochester, Rochester, MN
A
Aaron Hardin
Guardant Health, Palo Alto, CA
T
Thereasa Rich
Guardant Health, Palo Alto, CA
Q
Qian Shi
Related Articles from this Journal
Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer
Ismaela Anna Vascotto, Filippo Antonica et al.
Aug 2026
10.1200/jco-26-00658
Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial
Samer A. Srour, Jad Chahoud et al.
Aug 2026
10.1200/jco-26-00388
Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection
Risako Komata, Kenju Ando et al.
Aug 2026
10.1200/jco-26-00140
Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)
Ghayas C. Issa, Branko Cuglievan et al.
Aug 2026
10.1200/jco-26-01743
Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer
Irbaz Bin Riaz, R. Bryan Rumble et al.
Aug 2026
10.1200/jco-26-01001